Pan HJ - Search Results

1

Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: relation to dysregulated phosphatidylcholine metabolism.

Pan HJ, Lin Y, Chen YE, Vance DE, Leiter EH. Pan HJ, et al. Vascul Pharmacol. 2006 Jul;45(1):65-71. doi: 10.1016/j.vph.2005.11.011. Epub 2006 Jun 5. Vascul Pharmacol. 2006. PMID: 16750656

2

A polymorphism in New Zealand inbred mouse strains that inactivates phosphatidylcholine transfer protein.

Pan HJ, Agate DS, King BL, Wu MK, Roderick SL, Leiter EH, Cohen DE. Pan HJ, et al. FEBS Lett. 2006 Oct 30;580(25):5953-8. doi: 10.1016/j.febslet.2006.09.066. Epub 2006 Oct 6. FEBS Lett. 2006. PMID: 17046758 Free PMC article.

3

Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone.

Watkins SM, Reifsnyder PR, Pan HJ, German JB, Leiter EH. Watkins SM, et al. Among authors: pan hj. J Lipid Res. 2002 Nov;43(11):1809-17. doi: 10.1194/jlr.m200169-jlr200. J Lipid Res. 2002. PMID: 12401879 Free article.

4

Contributions of dysregulated energy metabolism to type 2 diabetes development in NZO/H1Lt mice with polygenic obesity.

Koza RA, Flurkey K, Graunke DM, Braun C, Pan HJ, Reifsnyder PC, Kozak LP, Leiter EH. Koza RA, et al. Among authors: pan hj. Metabolism. 2004 Jun;53(6):799-808. doi: 10.1016/j.metabol.2003.12.024. Metabolism. 2004. PMID: 15164332

5

Pharmacogenetic analysis of rosiglitazone-induced hepatosteatosis in new mouse models of type 2 diabetes.

Pan HJ, Reifsnyder P, Vance DE, Xiao Q, Leiter EH. Pan HJ, et al. Diabetes. 2005 Jun;54(6):1854-62. doi: 10.2337/diabetes.54.6.1854. Diabetes. 2005. PMID: 15919809

6

Differential endocrine responses to rosiglitazone therapy in new mouse models of type 2 diabetes.

Leiter EH, Reifsnyder PC, Zhang W, Pan HJ, Xiao Q, Mistry J. Leiter EH, et al. Among authors: pan hj. Endocrinology. 2006 Feb;147(2):919-26. doi: 10.1210/en.2005-0839. Epub 2005 Oct 27. Endocrinology. 2006. PMID: 16254032

7

Hyperglycemia induced down-regulation of renal P-glycoprotein expression.

Yeh SY, Pan HJ, Lin CC, Kao YH, Chen YH, Lin CJ. Yeh SY, et al. Among authors: pan hj. Eur J Pharmacol. 2012 Sep 5;690(1-3):42-50. doi: 10.1016/j.ejphar.2012.06.013. Epub 2012 Jun 18. Eur J Pharmacol. 2012. PMID: 22721613

8

Change in P-glycoprotein and caveolin protein expression in brain striatum capillaries in New Zealand obese mice with type 2 diabetes.

Wu KC, Pan HJ, Yin HS, Chen MR, Lu SC, Lin CJ. Wu KC, et al. Among authors: pan hj. Life Sci. 2009 Dec 16;85(23-26):775-81. doi: 10.1016/j.lfs.2009.10.014. Epub 2009 Nov 3. Life Sci. 2009. PMID: 19891976

9

Mutations in the SLC2A10 gene cause arterial abnormalities in mice.

Cheng CH, Kikuchi T, Chen YH, Sabbagha NG, Lee YC, Pan HJ, Chang C, Chen YT. Cheng CH, et al. Among authors: pan hj. Cardiovasc Res. 2009 Feb 1;81(2):381-8. doi: 10.1093/cvr/cvn319. Epub 2008 Nov 21. Cardiovasc Res. 2009. PMID: 19028722

10

[Influence of post-filter ionic calcium gradients on the longevity of CRRT local citrate anticoagulation in extracorporeal circulation].

Wang BD, Tang QR, Niroj M, Pan HJ, Zhang L. Wang BD, et al. Among authors: pan hj. Zhonghua Yi Xue Za Zhi. 2024 Nov 26;104(44):4081-4086. doi: 10.3760/cma.j.cn112137-20240509-01080. Zhonghua Yi Xue Za Zhi. 2024. PMID: 39573956 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters